Allen DL, Harrison BC, Maass A, Bell ML, Byrnes WC, Leinwand LA (2001) Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 90:1900–1908. https://doi.org/10.1152/jappl.2001.90.5.1900
CAS
Article
PubMed
Google Scholar
Annaheim S, Jacob M, Krafft A, Breymann C, Rehm M, Boutellier U (2016) RhEPO improves time to exhaustion by non-hematopoietic factors in humans. Eur J Appl Physiol 116:623–633. https://doi.org/10.1007/s00421-015-3322-6
CAS
Article
PubMed
Google Scholar
Atkinson TS, Kahn MJ (2020) Blood doping: then and now. A narrative review of the history, science and efficacy of blood doping in elite sport. Blood Rev 39:100632
CAS
Article
Google Scholar
Birzniece V (2015) Doping in sport: effects, harm and misconceptions. Intern Med J 45:239–248. https://doi.org/10.1111/imj.12629
CAS
Article
PubMed
Google Scholar
de Boer RA, Pinto YM, Suurmeijer AJH, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, van Veldhuisen DJ (2003) Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc Res 57:434–442
Article
Google Scholar
Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100:4802–4806. https://doi.org/10.1073/pnas.0630444100
CAS
Article
PubMed
PubMed Central
Google Scholar
Carraway MS, Suliman HB, Jones WS, Chen C-W, Babiker A, Piantadosi CA (2010) Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart. Circ Res 106:1722–1730. https://doi.org/10.1161/CIRCRESAHA.109.214353
CAS
Article
PubMed
PubMed Central
Google Scholar
Cheung Tung Shing KS, Broughton SE, Nero TL, Gillinder K, Ilsley MD, Ramshaw H, Lopez AF, Griffin MDW, Parker MW, Perkins AC, Dhagat U (2018) EPO does not promote interaction between the erythropoietin and beta-common receptors. Sci Rep 8:1–16. https://doi.org/10.1038/s41598-018-29865-x
CAS
Article
Google Scholar
Cohen RS, Karlin P, Yushak M, Mancini D, Maurer MS (2009) The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Hear Fail 16:96–103. https://doi.org/10.1111/j.1751-7133.2009.00135.x
CAS
Article
Google Scholar
Collino M, Thiemermann C, Cerami A, Brines M (2015) Flipping the molecular switch for innate protection and repair of tissues: long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacol Ther 151:32–40. https://doi.org/10.1016/j.pharmthera.2015.02.005
CAS
Article
PubMed
Google Scholar
Dorn GW, Vega RB, Kelly DP (2015) Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev 29:1981–1991
CAS
Article
Google Scholar
Ghezzi P, Bernaudin M, Bernaudinb M, Bianchi R, Bianchic R, Blomgren K, Brines M, Campana W, Cavaletti G, Cerami A, Chopp M, Coleman T, Digicaylioglu M, Ehrenreich H, Erbayraktar S, Erbayraktar Z, Gassmann M, Genc S, Gokmen N, Grasso G, Juul S, Lipton SA, Hand CC, Latini R, Lauria G, Leist M, Newton SS, Petit E, Probert L, Sfacteria A, Siren A-L, Talan M, Thiemermann C, Westenbrink D, Yaqoob M, Zhu C (2010) Erythropoietin: not just about erythropoiesis. Lancet (London, England) 375:2142. https://doi.org/10.1016/S0140-6736(10)60992-0
Article
Google Scholar
Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, LeBrasseur NK, Yan Z, Spiegelman BM (2007) Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J Biol Chem 282:30014–30021. https://doi.org/10.1074/jbc.M704817200
CAS
Article
PubMed
Google Scholar
Hardeman M, Alexy T, Brouwer B, Connes P, Jung F, Kuipers H, Baskurt OK (2014) EPO or PlacEPO? Science versus practical experience: panel discussion on efficacy of erythropoetin in improving performance. Biorheology 51:83–90. https://doi.org/10.3233/BIR-140655
CAS
Article
PubMed
Google Scholar
Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, Rodenburg RJ, van Veldhuisen DJ, de Boer RA, van der Meer P (2018) Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail 20:910–919. https://doi.org/10.1002/ejhf.1154
CAS
Article
PubMed
Google Scholar
Jia Y, Suzuki N, Yamamoto M, Gassmann M, Noguchi CT (2012) Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage. FASEB J 26:2847–2858. https://doi.org/10.1096/fj.11-196618
CAS
Article
PubMed
PubMed Central
Google Scholar
Konhilas JP, Widegren U, Allen DL, Paul AC, Cleary A, Leinwand LA (2005) Loaded wheel running and muscle adaptation in the mouse. Am J Physiol - Hear Circ Physiol 289:H455-65. https://doi.org/10.1152/ajpheart.00085.2005
CAS
Article
Google Scholar
Kuipers J, de Boer P, Giepmans BNG (2015) Scanning EM of non-heavy metal stained biosamples: large-field of view, high contrast and highly efficient immunolabeling. Exp Cell Res 337:202–207. https://doi.org/10.1016/j.yexcr.2015.07.012
CAS
Article
PubMed
Google Scholar
Kuipers J, Giepmans BNG (2020) Neodymium as an alternative contrast for uranium in electron microscopy. Histochem Cell Biol 153:271–277. https://doi.org/10.1007/s00418-020-01846-0
CAS
Article
PubMed
PubMed Central
Google Scholar
Lamon S, Russell AP (2013) The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know? Front Physiol 4:176. https://doi.org/10.3389/fphys.2013.00176
Article
PubMed
PubMed Central
Google Scholar
Lamon S, Zacharewicz E, Arentson-Lantz E, Della GPA, Ghobrial L, Gerlinger-Romero F, Garnham A, Paddon-Jones D, Russell AP (2016) Erythropoietin does not enhance skeletal muscle protein synthesis following exercise in young and older adults. Front Physiol 7:292. https://doi.org/10.3389/fphys.2016.00292
Article
PubMed
PubMed Central
Google Scholar
Lamon S, Zacharewicz E, Stephens AN, Russell AP (2014) EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis. Physiol Rep 2:e00256. https://doi.org/10.1002/phy2.256
CAS
Article
PubMed
PubMed Central
Google Scholar
Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, van Veldhuisen DJ, Schoemaker RG, van Gilst WH (2008) Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail 10:22–29. https://doi.org/10.1016/j.ejheart.2007.10.008
CAS
Article
PubMed
Google Scholar
Lu J, Dai Q, ming, Ma G shan, Zhu Y hong, Chen B, Li B, Yao Y yu, (2017) Erythropoietin attenuates cardiac dysfunction in rats by inhibiting endoplasmic reticulum stress-induced diabetic cardiomyopathy. Cardiovasc Drugs Ther 31:367–379. https://doi.org/10.1007/s10557-017-6742-1
CAS
Article
PubMed
Google Scholar
Lundby C, Olsen NV (2011) Effects of recombinant human erythropoietin in normal humans. J Physiol 589:1265–1271. https://doi.org/10.1113/jphysiol.2010.195917
CAS
Article
PubMed
Google Scholar
Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, Calbet JAL, Robach P (2007) Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J Physiol 578:309–314. https://doi.org/10.1113/jphysiol.2006.122689
CAS
Article
PubMed
Google Scholar
Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107:294–299. https://doi.org/10.1161/01.CIR.0000044914.42696.6A
CAS
Article
PubMed
Google Scholar
Manzanares G, Brito-Da-Silva G, Gandra PG (2019) Voluntary wheel running: patterns and physiological effects in mice. Brazilian J Med Biol Res 52https://doi.org/10.1590/1414-431X20187830
Meems LMG, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Silljé HHW, Ruifrok WPT, de Boer RA (2012) The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol 132:282–289. https://doi.org/10.1016/j.jsbmb.2012.06.004
CAS
Article
PubMed
Google Scholar
Mille-Hamard L, Billat VL, Henry E, Bonnamy B, Joly F, Benech P, Barrey E (2012) Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study. BMC Med Genomics 5:29. https://doi.org/10.1186/1755-8794-5-29
CAS
Article
PubMed
PubMed Central
Google Scholar
Muirhead N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, Parfrey P (1995) Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis 26:S1-24
CAS
Article
Google Scholar
Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15:387–407. https://doi.org/10.1038/s41569-018-0007-y
CAS
Article
PubMed
Google Scholar
Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Ishii N, Sugamura K, Shimokawa H (2007) Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 100:662–669. https://doi.org/10.1161/01.RES.0000260179.43672.fe
CAS
Article
PubMed
Google Scholar
Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y (2008) Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med 10:e36. https://doi.org/10.1017/S1462399408000860
Article
PubMed
PubMed Central
Google Scholar
Ogilvie M, Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT, Noguchi CT (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275:39754–39761. https://doi.org/10.1074/jbc.M004999200
CAS
Article
PubMed
Google Scholar
Ostrowski D, Heinrich R (2018) Alternative erythropoietin receptors in the nervous system. J Clin Med 7:24. https://doi.org/10.3390/jcm7020024
CAS
Article
PubMed Central
Google Scholar
Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3:1422–1434. https://doi.org/10.1038/nprot.2008.138
CAS
Article
PubMed
PubMed Central
Google Scholar
Pin F, Busquets S, Toledo M, Camperi A, Lopez-Soriano FJ, Costelli P, Argilés JM, Penna F (2015) Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations. Oncotarget 6:43202–43215. https://doi.org/10.18632/oncotarget.6439
Article
PubMed
PubMed Central
Google Scholar
Plenge U, Belhage B, Guadalupe-Grau A, Andersen PR, Lundby C, Dela F, Stride N, Pott FC, Helge JW, Boushel R (2012) Erythropoietin treatment enhances muscle mitochondrial capacity in humans. Front Physiol 3:50. https://doi.org/10.3389/fphys.2012.00050
Article
PubMed
PubMed Central
Google Scholar
Qaisar R, Bhaskaran S, Van Remmen H (2016) Muscle fiber type diversification during exercise and regeneration. Free Radic Biol Med 98:56–67. https://doi.org/10.1016/j.freeradbiomed.2016.03.025
CAS
Article
PubMed
Google Scholar
Quiros PM, Goyal A, Jha P, Auwerx J (2017) Analysis of mtDNA/nDNA ratio in mice. Curr Protoc Mouse Biol 7:47–54. https://doi.org/10.1002/cpmo.21
CAS
Article
PubMed
PubMed Central
Google Scholar
Rundqvist H, Rullman E, Sundberg CJ, Fischer H, Eisleitner K, Ståhlberg M, Sundblad P, Jansson E, Gustafsson T (2009) Activation of the erythropoietin receptor in human skeletal muscle. Eur J Endocrinol 161:427–434. https://doi.org/10.1530/EJE-09-0342
CAS
Article
PubMed
Google Scholar
Seo DY, Kwak HB, Kim AH, Park SH, Heo JW, Kim HK, Ko JR, Lee SJ, Bang HS, Sim JW, Kim M, Han J (2019) Cardiac adaptation to exercise training in health and disease. Pflugers Arch Eur. J. Physiol 472:155–168
Article
Google Scholar
Shimizu I, Minamino T (2016) Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97:245–262. https://doi.org/10.1016/j.yjmcc.2016.06.001
CAS
Article
PubMed
Google Scholar
Sokol E, Kramer D, Diercks GFH, Kuipers J, Jonkman MF, Pas HH, Giepmans BNG (2015) Large-scale electron microscopy maps of patient skin and mucosa provide insight into pathogenesis of blistering diseases. J Invest Dermatol 135:1763–1770. https://doi.org/10.1038/jid.2015.109
CAS
Article
PubMed
Google Scholar
Suresh S, Rajvanshi PK, Noguchi CT (2020) The Many facets of erythropoietin physiologic and metabolic response. Front Physiol 10:1534
Article
Google Scholar
Suzuki N, Ohneda O, Takahashi S, Higuchi M, Mukai HY, Nakahata T, Imagawa S, Yamamoto M (2002) Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100:2279–2288. https://doi.org/10.1182/blood-2002-01-0124
CAS
Article
PubMed
Google Scholar
Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H (2006) Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 71:466–477. https://doi.org/10.1016/j.cardiores.2006.05.010
CAS
Article
PubMed
Google Scholar
Teng R, Gavrilova O, Suzuki N, Chanturiya T, Schimel D, Hugendubler L, Mammen S, Yver DR, Cushman SW, Mueller E, Yamamoto M, Hsu LL, Noguchi CT (2011) Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2:520. https://doi.org/10.1038/ncomms1526
CAS
Article
PubMed
Google Scholar
Wang L, Di L, Noguchi CT (2014) Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci 10:921–939. https://doi.org/10.7150/ijbs.9518
CAS
Article
PubMed
PubMed Central
Google Scholar
Wang L, Jia Y, Rogers H, Suzuki N, Gassmann M, Wang Q, McPherron AC, Kopp JB, Yamamoto M, Noguchi CT (2013) Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation. Int J Biochem Cell Biol 45:1155–1164. https://doi.org/10.1016/j.biocel.2013.03.007
CAS
Article
PubMed
PubMed Central
Google Scholar
Wang L, Jia Y, Rogers H, Wu YP, Huang S, Noguchi CT (2012) GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1). J Biol Chem 287:30157–30169. https://doi.org/10.1074/jbc.M112.376640
CAS
Article
PubMed
PubMed Central
Google Scholar
Weiss K, Schär M, Panjrath GS, Zhang Y, Sharma K, Bottomley PA, Golozar A, Steinberg A, Gerstenblith G, Russell SD, Weiss RG (2017) Fatigability, exercise intolerance, and abnormal skeletal muscle energetics in heart failure. Circ Heart Fail 10:e004129. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004129
Article
PubMed
PubMed Central
Google Scholar
Westenbrink BD, De Boer RA, Voors AA, Van Gilst WH, Van Veldhuisen DJ (2008) Anemia in chronic heart failure: etiology and treatment options. Curr Opin Cardiol 23:141–147
Article
Google Scholar
Westenbrink BD, Oeseburg H, Kleijn L, van der Harst P, Belonje AMS, Voors AA, Schoemaker RG, de Boer RA, van Veldhuisen DJ, van Gilst WH (2008) Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Cardiovasc drugs Ther 22:265–274. https://doi.org/10.1007/s10557-008-6094-y
CAS
Article
PubMed
Google Scholar
Westenbrink BD, Ruifrok W-PT, Voors AA, Tilton RG, van Veldhuisen DJ, Schoemaker RG, van Gilst WH, de Boer RA (2010) Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 87:30–39. https://doi.org/10.1093/cvr/cvq041
CAS
Article
PubMed
Google Scholar
Yu H, Tigchelaar W, Koonen DPY, Patel HH, de Boer RA, van Gilst WH, Westenbrink BD, Silljé HHW (2013) AKIP1 expression modulates mitochondrial function in rat neonatal cardiomyocytes. PLoS ONE 8:e80815. https://doi.org/10.1371/journal.pone.0080815
CAS
Article
PubMed
PubMed Central
Google Scholar
Yu H, Tigchelaar W, Lu B, van Gilst W, de Boer R, Westenbrink B, Silljé H (2013) AKIP1, a cardiac hypertrophy induced protein that stimulates cardiomyocyte growth via the Akt pathway. Int J Mol Sci 14:21378–21393. https://doi.org/10.3390/ijms141121378
CAS
Article
PubMed
PubMed Central
Google Scholar
Yurista SR, Matsuura TR, Silljé HHW, Nijholt KT, McDaid KS, Shewale SV, Leone TC, Newman JC, Verdin E, van Veldhuisen DJ, de Boer RA, Kelly DP, Westenbrink BD (2020) Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure. Circ Hear Fail. https://doi.org/10.1161/circheartfailure.120.007684
Article
Google Scholar
Yurista SR, Silljé HHW, Nijholt KT, Dokter MM, van Veldhuisen DJ, de Boer RA, Westenbrink BD (2020) Factor Xa inhibition with apixaban does not influence cardiac remodelling in rats with heart failure after myocardial infarction. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-020-06999-7
Article
PubMed
PubMed Central
Google Scholar
Zhang Y, Wang L, Dey S, Alnaeeli M, Suresh S, Rogers H, Teng R, Noguchi CT (2014) Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci 15:10296–10333
Article
Google Scholar